Research Highlight | Published:

CNS CANCER

Lomustine–temozolomide combination efficacious in newly diagnosed glioblastoma

Nature Reviews Clinical Oncologyvolume 16page273 (2019) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Herrlinger, U. et al. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. Lancet 393, 678–688 (2019)

    Download references

    Author information

    Affiliations

    1. Nature Reviews Clinical Oncology

      • David Killock

    Authors

    1. Search for David Killock in:

    Corresponding author

    Correspondence to David Killock.

    About this article

    Publication history

    Published

    Issue Date

    DOI

    https://doi.org/10.1038/s41571-019-0192-6

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing